Citigroup’s NuVasive, Inc. NUVA Stock Holding History

Citigroup’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-66,000	Closed	-$3.45M	–	7786
2018 Q1	$3.45M	Buy	66,000 +51,000	+340%	+$2.59M	﹤0.01%	2115
2017 Q4	$877K	Sell	15,000 -9,000	-38%	-$510K	﹤0.01%	3468
2017 Q3	$1.33M	Sell	24,000 -16,000	-40%	-$1.06M	﹤0.01%	3072
2017 Q2	$3.08M	Buy	+40,000	New	+$2.99M	﹤0.01%	2134

Other funds holding NUVA

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Citigroup's NUVA Position: Q3 2023 in Review

Citigroup sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 384,383 shares — an estimated $16M sold.

Citigroup first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $54.3M in Q2 2022. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

Citigroup reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
Citigroup sold 384,383 NuVasive, Inc. shares in Q3 2023, an estimated $16M.
Citigroup first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
Citigroup's NuVasive, Inc. position peaked at $54.3M in Q2 2022.
2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.